Sympathoinhibitory function of the alpha(2A)-adrenergic receptor subtype

• Published in: Hypertension (Dallas, Tex. 1979) Vol. 34; no. 3; pp. 403 - 407
• Main Authors: Makaritsis, K P, Johns, C, Gavras, I, Altman, J D, Handy, D E, Bresnahan, M R, Gavras, H
• Format: Journal Article
• Language: English
• Published: United States 01.09.1999
• Subjects: Animals; Blood Pressure - drug effects; Blood Pressure - physiology; Body Weight; Catecholamines - metabolism; Heart Rate - physiology; Hypertension - genetics; Hypertension - physiopathology; Mice; Mice, Knockout; Receptors, Adrenergic, alpha-2 - genetics; Receptors, Adrenergic, alpha-2 - physiology; Sodium Chloride - pharmacology
• ISSN: 0194-911X
• DOI: 10.1161/01.HYP.34.3.403

Presynaptic alpha(2)-adrenergic receptors (alpha(2)-AR) are distributed throughout the central nervous system and are highly concentrated in the brain stem, where they contribute to neural baroreflex control of blood pressure (BP). To explore the role of the alpha(2A)-AR subtype in this function, we compared BP and plasma norepinephrine and epinephrine levels in genetically engineered mice with deleted alpha(2A)-AR gene to their wild-type controls. At baseline, the alpha(2A)-AR gene knockouts (n=11) versus controls (n=10) had higher systolic BP (123+/-2.5 versus 115+/-2.5 mm Hg, P<0. 05), heart rate (730+/-15 versus 600+/-18 b/min, P<0.001), and norepinephrine (1.005+/-0.078 versus 0.587+/-0.095 ng/mL, P<0.01), respectively. When submitted to subtotal nephrectomy and given 1% saline as drinking water, both alpha(2A)-AR gene knockouts (n=14) and controls (n=14) became hypertensive, but the former required 15. 6+/-2.5 days versus 29.3+/-1.4 days for the controls (P<0.001). End-point systolic BP was similar for both at 155+/-2.1 versus 152+/-5.2 mm Hg, but norepinephrine and epinephrine levels were twice as high in the knockouts at 1.386+/-0.283 and 0.577+/-0.143 versus 0.712+/-0.110 and 0.255+/-0.032 ng/mL, respectively, P<0.05 for both. We conclude that the alpha(2A)-AR subtype exerts a sympathoinhibitory effect, and its loss leads to a hypertensive, hyperadrenergic state.